BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hopkins S, Fakih M, Yang GY. Positron emission tomography as predictor of rectal cancer response during or following neoadjuvant chemoradiation. World J Gastrointest Oncol 2010; 2(5): 213-217 [PMID: 21160619 DOI: 10.4251/wjgo.v2.i5.213]
URL: https://www.wjgnet.com/1948-5204/full/v2/i5/213.htm
Number Citing Articles
1
Mohan Hingorani, John E. Hartley, John Greenman, John Macfie. Avoiding radical surgery after pre-operative chemoradiotherapy: A possible therapeutic option in rectal cancer?Acta Oncologica 2012; 51(3): 275 doi: 10.3109/0284186X.2011.636756
2
Hirotada Kittaka, Hidenori Takahashi, Hiroaki Ohigashi, Kunihito Gotoh, Terumasa Yamada, Yasuhiko Tomita, Yoshihisa Hasegawa, Masahiko Yano, Osamu Ishikawa. Role of 18F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Pathologic Response to Preoperative Chemoradiation Therapy in Patients With Resectable T3 Pancreatic CancerWorld Journal of Surgery 2013; 37(1): 169 doi: 10.1007/s00268-012-1775-x
3
F. Montravers, J.-N. Talbot. Tomographie par émission de positons en cancérologie digestiveEMC - Radiologie et imagerie médicale - Abdominale - Digestive 2012; 7(2): 1 doi: 10.1016/S1879-8527(12)55045-8
4
H. Akita, H. Takahashi, H. Ohigashi, A. Tomokuni, S. Kobayashi, K. Sugimura, N. Miyoshi, J.-H. Moon, M. Yasui, T. Omori, H. Miyata, M. Ohue, Y. Fujiwara, M. Yano, O. Ishikawa, M. Sakon. FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancerEuropean Journal of Surgical Oncology (EJSO) 2017; 43(6): 1061 doi: 10.1016/j.ejso.2017.03.015
5
Karina Dagre Magri, Fang Chia Bin, Fernanda Bellotti Formiga, Thiago da Silveira Manzione, Caroline Merci Caliari de Neves Gomes, Paulo de Azeredo Passos Candelári, Jorge Alberto Ortiz, Wilmar Artur Klug, José Mandia Neto, Peretz Capelhuchnik. Impact of neoadjuvant therapy in downstaging of lower rectal adenocarcinoma and the role of pelvic magnetic resonance in stagingRevista do Colégio Brasileiro de Cirurgiões 2016; 43(2): 102 doi: 10.1590/0100-69912016002006
6
Hirofumi Akita, Hidenori Takahashi, Hidetoshi Eguchi, Kei Asukai, Shinichiro Hasegawa, Hiroshi Wada, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Takehiro Noda, Kunihito Gotoh, Shogo Kobayashi, Yuichiro Doki, Masato Sakon. Difference between carbohydrate antigen 19‐9 and fluorine‐18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvant treatment in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma: Results of a dual‐center studyAnnals of Gastroenterological Surgery 2021; 5(3): 381 doi: 10.1002/ags3.12418
7
Theara C. Fagundes, Arnoldo Mafra, Rodrigo G. Silva, Ana C. G. Castro, Luciana C. Silva, Priscilla T. Aguiar, Josiane A. Silva, Eduardo P. Junior, Alexei M. Machado, Marcelo Mamede. Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer?Revista da Associação Médica Brasileira 2018; 64(2): 119 doi: 10.1590/1806-9282.64.02.119